TY - JOUR PY - 2005 DA - 2005// TI - Efficacy and safety of cholesterol-lowering treatment: Prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins JO - Lancet VL - 366 UR - https://doi.org/10.1016/S0140-6736(05)67394-1 DO - 10.1016/S0140-6736(05)67394-1 ID - ref1 ER - TY - JOUR AU - Cannon, C. P. AU - Blazing, M. A. AU - Giugliano, R. P. AU - McCagg, A. AU - White, J. A. AU - Theroux, P. PY - 2015 DA - 2015// TI - Ezetimibe sed to statin therapy after acute coronary syndromes JO - N Engl J Med VL - 372 UR - https://doi.org/10.1056/NEJMoa1410489 DO - 10.1056/NEJMoa1410489 ID - Cannon2015 ER - TY - STD TI - Bohula EA, Wiviott SD, Giugliano RP, Blazing MA, Park J-G, Murphy SA, et al. Prevention of stroke with the addition of ezetimibe to statin therapy in patients with acute coronary syndrome in IMPROVE-IT. Circulation. 2017. https://doi.org/10.1161/CIRCULATIONAHA.117.029095. ID - ref3 ER - TY - JOUR AU - Cohen, J. C. AU - Boerwinkle, E. AU - Mosley, T. H. AU - Hobbs, H. H. PY - 2006 DA - 2006// TI - Sequence variations in PCSK9, low LDL, and protection against coronary heart disease JO - N Engl J Med VL - 354 UR - https://doi.org/10.1056/NEJMoa054013 DO - 10.1056/NEJMoa054013 ID - Cohen2006 ER - TY - JOUR AU - Benn, M. AU - Nordestgaard, B. G. AU - Grande, P. AU - Schnohr, P. AU - Tybjaerg-Hansen, A. PY - 2010 DA - 2010// TI - PCSK9 R46L, low-density lipoprotein cholesterol levels, and risk of ischemic heart disease: 3 independent studies and meta-analyses JO - J Am Coll Cardiol VL - 55 UR - https://doi.org/10.1016/j.jacc.2010.02.044 DO - 10.1016/j.jacc.2010.02.044 ID - Benn2010 ER - TY - STD TI - Schmidt AF, Pearce LS, Wilkins JT, Overington JP, Hingorani A, Casas JP. PCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular disease. Cochrane Database Syst Rev. 2015;(6):CD011748. https://doi.org/10.1002/14651858.CD011748. ID - ref6 ER - TY - STD TI - Schwartz GG, Steg, Gabriel P, Szarek M, Bhatt DL, Bittner VA, Diaz R, Edelberg JM, Goodman SG, Hanotin C, Harrington RA, Jukema JW, Lecorps G, Mahaffey KW, Moryusef A, Pordy R, Quintero K, Roe MT, Sasiela WJ, Tamby JF, Tricoci P, White HD, Zeiher AM. Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome. N Engl J Med. 2018;379:2097-107. https://doi.org/10.1056/NEJMoa1801174. ID - ref7 ER - TY - JOUR AU - Hingorani, A. AU - Humphries, S. PY - 2005 DA - 2005// TI - Nature’s randomised trials JO - Lancet VL - 366 UR - https://doi.org/10.1016/S0140-6736(05)67767-7 DO - 10.1016/S0140-6736(05)67767-7 ID - Hingorani2005 ER - TY - JOUR AU - Swerdlow, D. I. AU - Preiss, D. AU - Kuchenbaecker, K. B. AU - Holmes, M. V. AU - Engmann, J. E. L. AU - Shah, T. PY - 2015 DA - 2015// TI - HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: Evidence from genetic analysis and randomised trials JO - Lancet VL - 385 UR - https://doi.org/10.1016/S0140-6736(14)61183-1 DO - 10.1016/S0140-6736(14)61183-1 ID - Swerdlow2015 ER - TY - JOUR AU - Swerdlow, D. I. AU - Hingorani, A. D. AU - Casas, J. P. AU - Consortium, I. M. R. PY - 2012 DA - 2012// TI - The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis JO - Lancet VL - 379 UR - https://doi.org/10.1016/S0140-6736(12)60110-X DO - 10.1016/S0140-6736(12)60110-X ID - Swerdlow2012 ER - TY - JOUR AU - Wensley, F. AU - Gao, P. AU - Burgess, S. AU - Kaptoge, S. AU - Angelantonio, E. AU - Shah, T. PY - 2011 DA - 2011// TI - Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data JO - BMJ VL - 342 UR - https://doi.org/10.1136/bmj.d548 DO - 10.1136/bmj.d548 ID - Wensley2011 ER - TY - JOUR AU - Casas, J. P. AU - Ninio, E. AU - Panayiotou, A. AU - Palmen, J. AU - Cooper, J. A. AU - Ricketts, S. L. PY - 2010 DA - 2010// TI - PLA2G7 genotype, lipoprotein-associated phospholipase A2 activity, and coronary heart disease risk in 10 494 cases and 15 624 controls of european ancestry JO - Circulation VL - 121 UR - https://doi.org/10.1161/CIRCULATIONAHA.109.923383 DO - 10.1161/CIRCULATIONAHA.109.923383 ID - Casas2010 ER - TY - JOUR AU - Sofat, R. AU - Hingorani, A. D. AU - Smeeth, L. AU - Humphries, S. E. AU - Talmud, P. J. AU - Cooper, J. PY - 2010 DA - 2010// TI - Separating the mechanism-based and off-target actions of cholesteryl ester transfer protein inhibitors with CETP gene polymorphisms JO - Circulation VL - 121 UR - https://doi.org/10.1161/CIRCULATIONAHA.109.865444 DO - 10.1161/CIRCULATIONAHA.109.865444 ID - Sofat2010 ER - TY - JOUR AU - Schmidt, A. F. AU - Swerdlow, D. D. I. AU - Holmes, M. M. V. AU - Patel, R. S. AU - Fairhurst-Hunter, Z. AU - Lyall, D. M. PY - 2016 DA - 2016// TI - PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation study JO - Lancet Diabetes Endocrinol VL - 0 ID - Schmidt2016 ER - TY - JOUR AU - Willer, C. J. AU - Sanna, S. AU - Jackson, A. U. AU - Scuteri, A. AU - Bonnycastle, L. L. AU - Clarke, R. PY - 2008 DA - 2008// TI - Newly identified loci that influence lipid concentrations and risk of coronary artery disease JO - Nat Genet VL - 40 UR - https://doi.org/10.1038/ng.76 DO - 10.1038/ng.76 ID - Willer2008 ER - TY - JOUR AU - Kircher, M. AU - Witten, D. M. AU - Jain, P. AU - O’Roak, B. J. AU - Cooper, G. M. AU - Shendure, J. PY - 2014 DA - 2014// TI - A general framework for estimating the relative pathogenicity of human genetic variants JO - Nat Genet VL - 46 UR - https://doi.org/10.1038/ng.2892 DO - 10.1038/ng.2892 ID - Kircher2014 ER - TY - STD TI - Schmidt AF, Pearce LS, Wilkins JT, Overington JP, Hingorani A, Casas JP. PCSK9 monoclonal antibodies for the primary and secondary prevention of cardiovascular disease. Cochrane Database Syst Rev. 2015;(6):CD011748. https://doi.org/10.1002/14651858.CD011748. ID - ref17 ER - TY - JOUR AU - Tomlinson, B. AU - Hu, M. AU - Zhang, Y. AU - Chan, P. AU - Liu, Z. M. PY - 2017 DA - 2017// TI - Alirocumab for the treatment of hypercholesterolemia JO - Expert Opin Biol Ther VL - 17 UR - https://doi.org/10.1080/14712598.2017.1305354 DO - 10.1080/14712598.2017.1305354 ID - Tomlinson2017 ER - TY - BOOK PY - 2017 DA - 2017// TI - R: A language and environment for statistical computing PB - R Foundation for Statistical Computing CY - Vienna ID - ref19 ER - TY - JOUR AU - Dias, C. S. AU - Shaywitz, A. J. AU - Wasserman, S. M. AU - Smith, B. P. AU - Gao, B. AU - Stolman, D. S. PY - 2012 DA - 2012// TI - Effects of AMG 145 on low-density lipoprotein cholesterol levels: results from 2 randomized, double-blind, placebo-controlled, ascending-dose phase 1 studies in healthy volunteers and hypercholesterolemic subjects on statins JO - J Am Coll Cardiol VL - 60 UR - https://doi.org/10.1016/j.jacc.2012.08.986 DO - 10.1016/j.jacc.2012.08.986 ID - Dias2012 ER - TY - STD TI - de Carvalho LSF, Campos AM, Sposito AC. Proprotein convertase Subtilisin/Kexin type 9 (PCSK9) inhibitors and incident type 2 diabetes mellitus: a systematic review and meta-analysis with over 96,000 patient-years. Diabetes Care. 2017. ID - ref21 ER - TY - JOUR AU - Lotta, L. A. AU - Sharp, S. J. AU - Burgess, S. AU - Perry, J. R. B. AU - Stewart, I. D. AU - Willems, S. M. PY - 2016 DA - 2016// TI - Association between low-density lipoprotein cholesterol–lowering genetic variants and risk of type 2 diabetes JO - JAMA VL - 316 UR - https://doi.org/10.1001/jama.2016.14568 DO - 10.1001/jama.2016.14568 ID - Lotta2016 ER - TY - JOUR AU - Ference, B. A. AU - Robinson, J. G. AU - Brook, R. D. AU - Catapano, A. L. AU - Chapman, M. J. AU - Neff, D. R. PY - 2016 DA - 2016// TI - Variation in PCSK9 and HMGCR and risk of cardiovascular disease and diabetes JO - N Engl J Med VL - 375 UR - https://doi.org/10.1056/NEJMoa1604304 DO - 10.1056/NEJMoa1604304 ID - Ference2016 ER - TY - JOUR AU - Fall, T. AU - Xie, W. AU - Poon, W. AU - Yaghootkar, H. AU - Magi, R. AU - Knowles, J. W. PY - 2015 DA - 2015// TI - Using genetic variants to assess the relationship between circulating lipids and type 2 diabetes JO - Diabetes VL - 64 UR - https://doi.org/10.2337/db14-1710 DO - 10.2337/db14-1710 ID - Fall2015 ER - TY - JOUR AU - White, J. AU - Swerdlow, D. I. AU - Preiss, D. AU - Fairhurst-Hunter, Z. AU - Keating, B. J. AU - Asselbergs, F. W. PY - 2016 DA - 2016// TI - Association of Lipid Fractions with Risks for coronary artery disease and diabetes JO - JAMA Cardiol VL - 366 ID - White2016 ER - TY - JOUR AU - Sattar, N. AU - Preiss, D. AU - Murray, H. M. AU - Welsh, P. AU - Buckley, B. M. AU - Craen, A. J. PY - 2010 DA - 2010// TI - Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials JO - Lancet VL - 375 UR - https://doi.org/10.1016/S0140-6736(09)61965-6 DO - 10.1016/S0140-6736(09)61965-6 ID - Sattar2010 ER - TY - JOUR AU - Smith, G. D. AU - Ebrahim, S. PY - 2003 DA - 2003// TI - “Mendelian randomization”: can genetic epidemiology contribute to understanding environmental determinants of disease? JO - Int J Epidemiol VL - 32 UR - https://doi.org/10.1093/ije/dyg070 DO - 10.1093/ije/dyg070 ID - Smith2003 ER - TY - JOUR AU - Burgess, S. AU - Zuber, V. AU - Valdes-Marquez, E. AU - Sun, B. B. AU - Hopewell, J. C. PY - 2017 DA - 2017// TI - Mendelian randomization with fine-mapped genetic data: choosing from large numbers of correlated instrumental variables JO - Genet Epidemiol VL - 41 UR - https://doi.org/10.1002/gepi.22077 DO - 10.1002/gepi.22077 ID - Burgess2017 ER - TY - JOUR AU - Burgess, S. AU - Butterworth, A. AU - Malarstig, A. AU - Thompson, S. G. PY - 2012 DA - 2012// TI - Use of Mendelian randomisation to assess potential benefit of clinical intervention JO - BMJ VL - 345 UR - https://doi.org/10.1136/bmj.e7325 DO - 10.1136/bmj.e7325 ID - Burgess2012 ER - TY - STD TI - Heart Protection Study Collaborative Group. Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20 536 people with cerebrovascular disease or other high-risk conditions. Lancet. 2004;363(9411):757–67. ID - ref30 ER - TY - JOUR AU - Amarenco, P. AU - Bogousslavsky, J. AU - Callahan, A. AU - Goldstein, L. B. AU - Hennerici, M. AU - Rudolph, A. E. PY - 2006 DA - 2006// TI - High-dose atorvastatin after stroke or transient ischemic attack JO - N Engl J Med VL - 355 UR - https://doi.org/10.1056/NEJMoa061894 DO - 10.1056/NEJMoa061894 ID - Amarenco2006 ER - TY - JOUR AU - Collins, R. AU - Reith, C. AU - Emberson, J. AU - Armitage, J. AU - Baigent, C. AU - Blackwell, L. PY - 2016 DA - 2016// TI - Interpretation of the evidence for the effi cacy and safety of statin therapy JO - Lancet VL - 388 UR - https://doi.org/10.1016/S0140-6736(16)31357-5 DO - 10.1016/S0140-6736(16)31357-5 ID - Collins2016 ER - TY - JOUR AU - Giugliano, R. P. AU - Mach, F. AU - Zavitz, K. AU - Kurtz, C. AU - Im, K. AU - Kanevsky, E. PY - 2017 DA - 2017// TI - Cognitive function in a randomized trial of Evolocumab JO - N Engl J Med VL - 377 UR - https://doi.org/10.1056/NEJMoa1701131 DO - 10.1056/NEJMoa1701131 ID - Giugliano2017 ER - TY - JOUR AU - Zhang, L. AU - Song, K. AU - Zhu, M. AU - Shi, J. AU - Zhang, H. AU - Xu, L. PY - 2016 DA - 2016// TI - Proprotein convertase subtilisin/kexin type 9 (PCSK9) in lipid metabolism, atherosclerosis and ischemic stroke JO - Int J Neurosci VL - 126 ID - Zhang2016 ER - TY - JOUR AU - Cariou, B. AU - Si-Tayeb, K. AU - May, C. PY - 2015 DA - 2015// TI - Role of PCSK9 beyond liver involvement JO - Curr Opin Lipidol VL - 26 UR - https://doi.org/10.1097/MOL.0000000000000180 DO - 10.1097/MOL.0000000000000180 ID - Cariou2015 ER - TY - JOUR AU - Hu, Y. -. J. Y. J. AU - Schmidt, A. F. A. F. AU - Dudbridge, F. AU - Holmes, M. V. M. V. AU - Brophy, J. M. AU - Tragante, V. PY - 2017 DA - 2017// TI - Impact of selection Bias on estimation of subsequent event risk JO - Circ Cardiovasc Genet VL - 10 UR - https://doi.org/10.1161/CIRCGENETICS.116.001616 DO - 10.1161/CIRCGENETICS.116.001616 ID - Hu2017 ER - TY - JOUR AU - Zewinger, S. AU - Kleber, M. E. AU - Tragante, V. AU - McCubrey, R. O. AU - Schmidt, A. F. AU - Direk, K. PY - 2017 DA - 2017// TI - Relations between lipoprotein(a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease: a molecular and genetic association study JO - Lancet Diabetes Endocrinol VL - 5 UR - https://doi.org/10.1016/S2213-8587(17)30096-7 DO - 10.1016/S2213-8587(17)30096-7 ID - Zewinger2017 ER - TY - JOUR AU - Patel, R. S. AU - Asselbergs, F. W. PY - 2015 DA - 2015// TI - The GENIUS-CHD consortium JO - Eur Heart J VL - 36 ID - Patel2015 ER -